An opioid-like system regulating feeding behavior in C. Elegans

eLife

Volumn 2015, Issue 4, 2015, Pages 1-19

  Cheong, Mi Cheong ^a,b   Artyukhin, Alexander B ^a,c   You, Young Jai ^a   Avery, Leon ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Boyce Thompson Institute for Plant Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; LOPERAMIDE; MORPHINE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; NEUROPEPTIDE; NLP 24; NLP 3; NPR 17; OPIATE; OPIATE RECEPTOR; UNCLASSIFIED DRUG; CAENORHABDITIS ELEGANS PROTEIN;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CAENORHABDITIS ELEGANS; CALCIUM TRANSPORT; CONTROLLED STUDY; FEEDING BEHAVIOR; GENE SEQUENCE; HUMAN; HUMAN CELL; LOCOMOTION; NONHUMAN; PHARYNX; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STARVATION; TRANSGENICS; AMINO ACID SEQUENCE; ANIMAL; CONSERVED SEQUENCE; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NERVE CELL; PHYSIOLOGY;

CAENORHABDITIS ELEGANS; INVERTEBRATA; MAMMALIA;

AMINO ACID SEQUENCE; ANIMALS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CONSERVED SEQUENCE; FEEDING BEHAVIOR; GENE EXPRESSION REGULATION; MOLECULAR SEQUENCE DATA; MORPHINE; NALOXONE; NEURONS; NEUROPEPTIDES; RECEPTORS, OPIOID; SIGNAL TRANSDUCTION; STARVATION;

EID: 85044697434     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/elife.06683     Document Type: Article

References (76)

1. Akil H, Owens C, Gutstein H, Taylor L, Curran E, Watson S. 1998. Endogenous opioids: overview and current issues. Drug and Alcohol Dependence 51:127–140. doi: 10.1016/S0376-8716(98)00071-4.
2. Albertson DG, Thomson JN. 1976. The pharynx of Caenorhabditis elegans. Philosophical Transactions of the Royal Society of London Series B, Biological Sciences 275:299–325. doi: 10.1098/rstb.1976.0085.
3. Ardelli BF, Prichard RK. 2013. Inhibition of P-glycoprotein enhances sensitivity of Caenorhabditis elegans to ivermectin. Veterinary Parasitology 191:264–275. doi: 10.1016/j.vetpar.2012.09.021.
4. Avery L. 1993. The genetics of feeding in Caenorhabditis elegans. Genetics 133:897–917.
5. Avery L. 2012. C. elegans feeding. Wormbook 1–23. doi: 10.1895/wormbook.1.150.1.
6. Avery L, Horvitz HR. 1989. Pharyngeal pumping continues after laser killing of the pharyngeal nervous system of C. elegans. Neuron 3:473–485. doi: 10.1016/0896-6273(89)90206-7.
7. Avery L, Horvitz HR. 1990. Effects of starvation and neuroactive drugs on feeding in Caenorhabditis elegans. The Journal of Experimental Zoology 253:263–270. doi: 10.1002/jez.1402530305.
8. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR. 2002. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418:650–654. doi: 10.1038/nature00887.
9. Ben Arous J, Laffont S, Chatenay D. 2009. Molecular and sensory basis of a food related two-state behavior in C. elegans. PLOS ONE 4:e7584. doi: 10.1371/journal.pone.0007584.
10. Beverly M, Anbil S, Sengupta P. 2011. Degeneracy and neuromodulation among thermosensory neurons contribute to robust thermosensory behaviors in Caenorhabditis elegans. The Journal of Neuroscience 31: 11718–11727. doi: 10.1523/JNEUROSCI.1098-11.2011.
11. Bishop NA, Guarente L. 2007. Two neurons mediate diet-restriction-induced longevity in C. elegans. Nature 447: 545–549. doi: 10.1038/nature05904.
12. Bodnar RJ. 2004. Endogenous opioids and feeding behavior: a 30-year historical perspective. Peptides 25: 697–725. doi: 10.1016/j.peptides.2004.01.006.
13. Brady LS, Smith MA, Gold PW, Herkenham M. 1990. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology 52:441–447. doi: 10.1159/000125626.
14. Broeks A, Gerrard B, Allikmets R, Dean M, Plasterk RH. 1996. Homologs of the human multidrug resistance genes MRP and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegans. The EMBO Journal 15:6132–6143. http://www.wormbase.org/db/misc/paper?name=WBPaper00002619.
15. Challis BG, Pinnock SB, Coll AP, Carter RN, Dickson SL, O’Rahilly S. 2003. Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochemical and Biophysical Research Communications 311:915–919. doi: 10.1016/j.bbrc.2003.10.089.
16. Chelur DS, Chalfie M. 2007. Targeted cell killing by reconstituted caspases. Proceedings of the National Academy of Sciences of USA 104:2283–2288. doi: 10.1073/pnas.0610877104.
17. Chen Y, Mestek A, Liu J, Yu L. 1993. Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors. The Biochemical Journal 295:625–628.
18. Chiang JT, Steciuk M, Shtonda B, Avery L. 2006. Evolution of pharyngeal behaviors and neuronal functions in freeliving soil nematodes. The Journal of Experimental Biology 209:1859–1873. doi: 10.1242/jeb.02165.
19. Choy RK, Thomas JH. 1999. Fluoxetine-resistant mutants in C. elegans define a novel family of transmembrane proteins. Molecular Cell 4:143–152. doi: 10.1016/S1097-2765(00)80362-7.
20. Dallman MF, Akana SF, Bhatnagar S, Bell ME, Choi S, Chu A, Horsley C, Levin N, Meijer O, Soriano LR, Strack AM, Viau V. 1999. Starvation: early signals, sensors, and sequelae. Endocrinology 140:4015–4023. doi: 10.1210/endo.140.9.7001.
21. DeHaven-Hudkins DL, Burgos LC, Cassel JA, Daubert JD, DeHaven RN, Mansson E, Nagasaka H, Yu G, Yaksh T. 1999. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity. The Journal of Pharmacology and Experimental Therapeutics 289:494–502.
22. Dereeper A, Guignon V, Blanc G, Audic S, Buffet S, Chevenet F, Dufayard JF, Guindon S, Lefort V, Lescot M, Claverie JM, Gascuel O. 2008. Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Research 36:W465–W469. doi: 10.1093/nar/gkn180.
23. Fares H, Grant B. 2002. Deciphering endocytosis in Caenorhabditis elegans. Traffic 3:11–19. doi: 10.1034/j.1600-0854.2002.30103.x.
24. Fire A, White Harrison S, Dixon D. 1990. A modular set of lacZ fusion vectors for studying gene expression in Caenorhabditis elegans. Gene 93:189–198. doi: 10.1016/0378-1119(90)90224-F.
25. Flavell SW, Pokala N, Macosko EZ, Albrecht DR, Larsch J, Bargmann CI. 2013. Serotonin and the neuropeptide PDF initiate and extend opposing behavioral states in C. elegans. Cell 154:1023–1035. doi: 10.1016/j.cell.2013.08.001.
26. Fujii H, Narita M, Mizoguchi H, Hirokawa J, Kawai K, Tanaka T, Tseng LF, Nagase H. 2004. Rational drug design and synthesis of a selective opioid receptor antagonist on the basis of the accessory site concept. Bioorganic & Medicinal Chemistry Letters 14:4241–4243. doi: 10.1016/j.bmcl.2004.06.004.
27. Fujiwara M, Sengupta P, McIntire SL. 2002. Regulation of body Size and behavioral state of C. elegans by sensory perception and the EGL-4 cGMP-dependent protein kinase. Neuron 36:1091–1102. doi: 10.1016/S0896-6273(02)01093-0.
28. Gallagher T, Bjorness T, Greene R, You YJ, Avery L. 2013a. The geometry of locomotive behavioral states in C. elegans. PLOS ONE 8:e59865. doi: 10.1371/journal.pone.0059865.
29. Gallagher T, Kim J, Oldenbroek M, Kerr R, You YJ. 2013b. ASI regulates satiety quiescence in C. elegans. The Journal of Neuroscience 33:9716–9724. doi: 10.1523/JNEUROSCI.4493-12.2013.
30. Gibbs J, Young RC, Smith GP. 1973. Cholecystokinin decreases food intake in rats. Journal of Comparative and Physiological Psychology 84:488–495. doi: 10.1037/h0034870.
31. Gosnell BA, Levine AS, Morley JE. 1986. The stimulation of food intake by selective agonists of mu, kappa and delta opioid receptors. Life Sciences 38:1081–1088. doi: 10.1016/0024-3205(86)90243-2.
32. Grandison L, Guidotti A. 1977. Stimulation of food intake by muscimol and beta endorphin. Neuropharmacology 16:533–536. http://www.sciencedirect.com/science/article/pii/0028390877900193. doi: 10.1016/0028-3908(77)90019-3.
33. Greer ER, Pérez CL, Van Gilst MR, Lee BH, Ashrafi K. 2008. Neural Molecular Dissection of a C. elegans sensory Circuit that regulates fat and feeding. Cell Metabolism 8:118–131. doi: 10.1016/j.cmet.2008.06.005.
34. Harris G, Mills H, Wragg R, Hapiak V, Castelletto M, Korchnak A, Komuniecki RW. 2010. The monoaminergic modulation of sensory-mediated aversive responses in Caenorhabditis elegans requires glutamatergic/peptidergic cotransmission. The Journal of Neuroscience 30:7889–7899. doi: 10.1523/JNEUROSCI.0497-10.2010.
35. Harrison LM, Kastin AJ, Weber JT, Banks WA, Hurley DL, Zadina JE. 1994. The opiate system in invertebrates. Peptides 15:1309–1329. doi: 10.1016/0196-9781(94)90159-7.
36. Hobert O. 2002. PCR fusion-based approach to create reporter gene constructs for expression analysis in transgenic C. elegans. Biotechniques 32:728–730.
37. Hobson RJ, Hapiak VM, Xiao H, Buehrer KL, Komuniecki PR, Komuniecki RW. 2006. SER-7, a Caenorhabditis elegans 5-HT7-like receptor, is essential for the 5-HT stimulation of pharyngeal pumping and egg laying. Genetics 172:159–169. doi: 10.1534/genetics.105.044495.
38. Holtzman SG. 1974. Behavioral effects of separate and combined administration of naloxone and d-amphetamine. The Journal of Pharmacology and Experimental Therapeutics 189:51–60.
39. Horvitz HR, Chalfie M, Trent C, Sulston JE, Evans PD. 1982. Serotonin and octopamine in the nematode Caenorhabditis elegans. Science 216:1012–1014. doi: 10.1126/science.6805073.
40. Husson SJ, Clynen E, Baggerman G, Janssen T, Schoofs L. 2006. Defective processing of neuropeptide precursors in Caenorhabditis elegans lacking proprotein convertase 2 (KPC-2/EGL-3): mutant analysis by mass spectrometry. Journal of Neurochemistry 98:1999–2012. doi: 10.1111/j.1471-4159.2006.04014.x.
41. Inoue T, Thomas JH. 2000. Targets of TGF-beta signaling in Caenorhabditis elegans dauer formation. Developmental Biology 217:192–204. doi: 10.1006/dbio.1999.9545.
42. Jackson A, Cooper SJ. 1986. An observational analysis of the effect of the selective kappa opioid agonist, U-50,488H, on feeding and related behaviours in the rat. Psychopharmacology 90:217–221. doi: 10.1007/BF00181245.
43. Janssen T, Husson SJ, Lindemans M, Mertens I, Rademakers S, Ver Donck K, Geysen J, Jansen G, Schoofs L. 2008a. Functional characterization of three G protein-coupled receptors for pigment dispersing factors in Caenorhabditis elegans. The Journal of Biological Chemistry 283:15241–15249. doi: 10.1074/jbc.M709060200.
44. Janssen T, Meelkop E, Lindemans M, Verstraelen K, Husson SJ, Temmerman L, Nachman RJ, Schoofs L. 2008b. Discovery of a cholecystokinin-gastrin-like signaling system in nematodes. Endocrinology 149:2826–2839. doi: 10.1210/en.2007-1772.
45. Jenck F, Gratton A, Wise RA. 1987. Opioid receptor subtypes associated with ventral tegmental facilitation of lateral hypothalamic brain stimulation reward. Brain Research 423:34–38. doi: 10.1016/0006-8993(87)90821-3.
46. Kamath RS, Ahringer J. 2003. Genome-wide RNAi screening in Caenorhabditis elegans. Methods 30:313–321. doi: 10.1016/S1046-2023(03)00050-1.
47. Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G. 1997. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277:942–946. doi: 10.1126/science.277.5328.942.
48. Lee BH, Ashrafi K. 2008. A TRPV channel modulates C. elegans neurosecretion, larval starvation survival, and adult lifespan. PLOS Genetics 4:e1000213. doi: 10.1371/journal.pgen.1000213.
49. Li C, Kim K. 2008. Neuropeptides. WormBook 1–36. doi: 10.1895/wormbook.1.142.1.
50. Li D, Olszewski PK, Shi Q, Grace MK, Billington CJ, Kotz CM, Levine AS. 2006. Effect of opioid receptor ligands injected into the rostral lateral hypothalamus on c-fos and feeding behavior. Brain Research 1096:120–124. doi: 10.1016/j.brainres.2006.04.031.
51. Margules DL, Moisset B, Lewis MJ, Shibuya H, Pert CB. 1978. beta-Endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa). Science 202:988–991. doi: 10.1126/science.715455.
52. Martin WR, Wikler A, Eades CG, Pescor FT. 1963. Tolerance to and physical dependence on morphine in rats. Psychopharmacologia 4:247–260. doi: 10.1007/BF00408180.
53. McCarthy L, Wetzel M, Sliker JK, Eisenstein TK, Rogers TJ. 2001. Opioids, opioid receptors, and the immune response. Drug and Alcohol Dependence 62:111–123. doi: 10.1016/S0376-8716(00)00181-2.
54. McKay JP, Raizen DM, Gottschalk A, Schafer WR, Avery L. 2004. eat-2 and eat-18 are required for nicotinic neurotransmission in the Caenorhabditis elegans pharynx. Genetics 166:161–169. doi: 10.1534/genetics.166.1.161.
55. Meister B. 2007. Neurotransmitters in key neurons of the hypothalamus that regulate feeding behavior and body weight. Physiology & Behavior 92:263–271. doi: 10.1016/j.physbeh.2007.05.021.
56. Miedel MT, Graf NJ, Stephen KE, Long OS, Pak SC, Perlmutter DH, Silverman GA, Luke CJ. 2012. A pro-cathepsin L mutant is a luminal substrate for endoplasmic-reticulum-associated degradation in C. elegans. PLOS ONE 7: e40145. doi: 10.1371/journal.pone.0040145.
57. Naleid AM, Grace MK, Chimukangara M, Billington CJ, Levine AS. 2007. Paraventricular opioids alter intake of high-fat but not high-sucrose diet depending on diet preference in a binge model of feeding. American Journal of Physiology Regulatory, Integrative and Comparative Physiology 293:R99–R105. doi: 10.1152/ajpregu.00675.2006.
58. Nathoo AN, Moeller RA, Westlund BA, Hart AC. 2001. Identification of neuropeptide-like protein gene families in Caenorhabditis elegans and other species. Proceedings of the National Academy of Sciences of USA 98: 14000–14005. doi: 10.1073/pnas.241231298.
59. Niacaris T, Avery L. 2003. Serotonin regulates repolarization of the C. elegans pharyngeal muscle. The Journal of Experimental Biology 206:223–231. doi: 10.1242/jeb.00101.
60. Partridge FA, Tearle AW, Gravato-Nobre MJ, Schafer WR, Hodgkin J. 2008. The C. elegans glycosyltransferase BUS-8 has two distinct and essential roles in epidermal morphogenesis. Developmental Biology 317:549–559. doi: 10.1016/j.ydbio.2008.02.060.
61. Pujol N, Zugasti O, Wong D, Couillault C, Kurz CL, Schulenburg H, Ewbank JJ. 2008. Anti-fungal innate immunity in C. elegans is enhanced by evolutionary diversification of antimicrobial peptides. PLOS Pathogens 4:e1000105. doi: 10.1371/journal.ppat.1000105.
62. Raizen D, Song B, Trojanowski N, You YJ. 2012. Methods for measuring pharyngeal behaviors. Wormbook 1–13. doi: 10.1895/wormbook.1.154.1.
63. Raizen DM, Lee RY, Avery L. 1995. Interacting genes required for pharyngeal excitation by motor neuron MC in Caenorhabditis elegans. Genetics 141:1365–1382.
64. Shtonda BB, Avery L. 2006. Dietary choice behavior in Caenorhabditis elegans. The Journal of Experimental Biology 209:89–102. doi: 10.1242/jeb.01955.
65. Sieburth D, Madison JM, Kaplan JM. 2007. PKC-1 regulates secretion of neuropeptides. Nature Neuroscience 10: 49–57. doi: 10.1038/nn1810.
66. Simmer F, Tijsterman M, Parrish S, Koushika SP, Nonet ML, Fire A, Ahringer J, Plasterk RH. 2002. Loss of the putative RNA-directed RNA polymerase RRF-3 makes C. elegans hypersensitive to RNAi. Current Biology 12: 1317–1319. doi: 10.1016/S0960-9822(02)01041-2.
67. Snyder SH, Pasternak GW. 2003. Historical review: opioid receptors. Trends in Pharmacological Sciences 24: 198–205. doi: 10.1016/S0165-6147(03)00066-X.
68. Tepperman FS, Hirst M. 1983. Effect of intrahypothalamic injection of [D-Ala2,D-Leu5]enkephalin on feeding and temperature in the rat. European Journal of Pharmacology 96:243–249. doi: 10.1016/0014-2999(83)90313-8.
69. Timmons L, Court DL, Fire A. 2001. Ingestion of bacterially expressed dsRNAs can produce specific and potent genetic interference in Caenorhabditis elegans. Gene 263:103–112. doi: 10.1016/S0378-1119(00)00579-5.
70. Torres JB, Evangelista WS, Barras R, Guedes RN. 2002. Dispersal of Podisus nigrispinus (Het., Pentatomidae) nymphs preyino on tomato leafminer: effect of predator release time, density and satiation level. Journal of Applied Entomology 126:326–332. doi: 10.1046/j.1439-0418.2002.00653.x.
71. Towett P, Kanui T, Juma F. 2006. Stimulation of mu and delta opioid receptors induces hyperalgesia while stimulation of kappa receptors induces antinociception in the hot plate test in the naked mole-rat (Heterocephalus glaber). Brain Research Bulletin 71:60–68. http://www.sciencedirect.com/science/article/pii/S0361923006002449. doi: 10.1016/j.brainresbull.2006.08.001.
72. Troemel ER, Chu SW, Reinke V, Lee SS, Ausubel FM, Kim DH. 2006. p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLOS Genetics 2:1725–1739. doi: 10.1371/journal.pgen.0020183.
73. Vaswani KK, Tejwani GA. 1986. Food deprivation-induced changes in the level of opioid peptides in the pituitary and brain of rat. Life Sciences 38:197–201. doi: 10.1016/0024-3205(86)90012-3.
74. Wang D, Kennedy S, Conte D Jr, Kim JK, Gabel HW, Kamath RS, Mello CC, Ruvkun G. 2005. Somatic misexpression of germline P granules and enhanced RNA interference in retinoblastoma pathway mutants. Nature 436:593–597. doi: 10.1038/nature04010.
75. Wang ZW, Saifee O, Nonet ML, Salkoff L. 2001. SLO-1 potassium channels control quantal content of neurotransmitter release at the C. elegans neuromuscular junction. Neuron 32:867–881. doi: 10.1016/S0896-6273(01)00522-0.
76. You Y, Kim J, Raizen DM, Avery L. 2008. Insulin, cGMP, and TGF-beta signals regulate food intake and quiescence in C. elegans: a model for satiety. Cell Metabolism 7:249–257. doi: 10.1016/j.cmet.2008.01.005.